This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics


  • 00
  • 00
  • 00
  • 00
Delivered as Hybrid Event from 16-18 November 2022
Live In-Person Conference Delivered 16-18 NovemberAustria Center Vienna

Arne Berthelmann, PhD
Director R&D at Bachem AG


Arne Berthelmann studied chemistry at Humboldt University Berlin, Germany. He then joined the group of Prof. J. Eichler at Friedrich Alexander University Erlangen, where he received his PhD in 2014 with a thesis on peptide inhibitor and vaccine design. Arne joined Bachem in the same year as a project chemist and very soon took over the position of team leader of the API CMC development group. After increasing responsibilities in process development, risk analysis and process characterization of large-scale SPPS projects, he became Director of Research and Development at Bachem in 2019.

Agenda Sessions

  • Process Development of an Efficient Large-Scale Manufacturing Process of a PEG-ylated Peptide: Pegcetacoplan